| Literature DB >> 28176767 |
Angélique Quartier1,2,3,4, Hélène Poquet5,6, Brigitte Gilbert-Dussardier7, Massimiliano Rossi8, Anne-Sophie Casteleyn9, Vincent des Portes10, Claire Feger11, Elsa Nourisson11, Paul Kuentz5,6, Claire Redin1,2,3,4, Julien Thevenon5,6, Anne-Laure Mosca-Boidron12, Patrick Callier12, Jean Muller11,13, Gaetan Lesca8, Frédéric Huet6, Véronique Geoffroy13, Salima El Chehadeh6,14, Matthieu Jung1,2,3,4, Benoit Trojak15, Stéphanie Le Gras1,2,3,4, Daphné Lehalle5, Bernard Jost1,2,3,4, Stéphanie Maury14, Alice Masurel6, Patrick Edery8, Christel Thauvin-Robinet5,6, Bénédicte Gérard11, Jean-Louis Mandel1,2,3,4,11,16,17, Laurence Faivre5,6, Amélie Piton1,11.
Abstract
Fragile-X syndrome (FXS) is a frequent genetic form of intellectual disability (ID). The main recurrent mutagenic mechanism causing FXS is the expansion of a CGG repeat sequence in the 5'-UTR of the FMR1 gene, therefore, routinely tested in ID patients. We report here three FMR1 intragenic pathogenic variants not affecting this sequence, identified using high-throughput sequencing (HTS): a previously reported hemizygous deletion encompassing the last exon of FMR1, too small to be detected by array-CGH and inducing decreased expression of a truncated form of FMRP protein, in three brothers with ID (family 1) and two splice variants in boys with sporadic ID: a de novo variant c.990+1G>A (family 2) and a maternally inherited c.420-8A>G variant (family 3). After clinical reevaluation, the five patients presented features consistent with FXS (mean Hagerman's scores=15). We conducted a systematic review of all rare non-synonymous variants previously reported in FMR1 in ID patients and showed that six of them are convincing pathogenic variants. This study suggests that intragenic FMR1 variants, although much less frequent than CGG expansions, are a significant mutational mechanism leading to FXS and demonstrates the interest of HTS approaches to detect them in ID patients with a negative standard work-up.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28176767 PMCID: PMC5386424 DOI: 10.1038/ejhg.2016.204
Source DB: PubMed Journal: Eur J Hum Genet ISSN: 1018-4813 Impact factor: 4.246